Patent · US Active

Phosphatidylinositol 3-kinase inhibitors

US10479770B2 · kind B2 · utility

0Cited by
45References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 21, 2017
Grant dateNov 19, 2019
Priority date—
Expiry dateSep 21, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2300/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application provides the compounds of formula I or pharmaceutically acceptable salts, isomers, tautomer, or a mixture thereof, wherein t, R1, R2, R3, R4, and R6 are as described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.